General Announcement::ASX:TLX Telix Q3 2024 Revenue and Business Update

Issuer & Securities

Issuer/ Manager
TELIX PHARMACEUTICALS LIMITED
Securities
TELIXPHAR A$650M2.375%N290730 - XS2862961492 - JWQB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
17-Oct-2024 14:15:35
Status
New
Announcement Sub Title
ASX:TLX Telix Q3 2024 Revenue and Business Update
Announcement Reference
SG241017OTHRXZZK
Submitted By (Co./ Ind. Name)
Genevieve Ryan
Designation
Company Secretary
Effective Date and Time of the event
17/10/2024 17:00:00
Description (Please provide a detailed description of the event in the box below)
ASX:TLX Telix Q3 2024 Revenue and Business Update

Attachments

20241017 Q3 2024 Business Update vFINAL.pdf
Total size =247K